Aggressive surgery for stage III/IV epithelial ovarian cancer
Gynecologic Oncology Aug 16, 2017
Tate S et al. – In the current study it was shown that outcomes improved after implementing aggressive surgery for advanced ovarian cancer.
Methods
- 106 patients with stage III/IV ovarian, fallopian, and peritoneal cancer undergoing elective aggressive surgery were studied.
Results
- The median progression-free and overall survival rates increased from 14.6 and 38.1?months before implementation of aggressive surgery, respectively, to 25.0 and 68.5?months after implementation, respectively.
- Complete resection was achieved in 83 of 106 patients, and the surgical complexity score was high (>8) in 61 patients.
- There were no mortality within 12?weeks of surgery.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries